BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Antimicrobial platform - BTX 1801 Phase 2a clinical study, page-8

  1. 2,815 Posts.
    lightbulb Created with Sketch. 603
    Yes Bee:

    "Twelve companies making twelve things they have never made before ..." and enough of the twelve made sufficient mess of the trial that they managed to turn the Australian results upside down, rather than just producing burnt porridge.

    ... and it all happened by accident.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.